Evercore ISI Sticks to Their Hold Rating for Caribou Biosciences (CRBU)
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Hold rating on Caribou Biosciences (CRBU – Research Report), with a ...
Evercore ISI Reaffirms Their Buy Rating on Akero Therapeutics (AKRO)
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Akero Therapeutics (AKRO – Research Report), with a ...
Rotten Tomatoes2y
Wanted Bayko No. 1
Link to 100 Best Movies of 1975, Ranked by Tomatometer 25 Most Popular TV Shows Right Now: What to Watch on Streaming Link to 25 Most Popular TV Shows Right Now: What to Watch on Streaming What to ...
Hosted on MSN28d
CRISPR Therapeutics stock rises following analyst upgrade
However, analysts are now seeing a potential upside of over 100% for the stock. Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's ...
Seeking Alpha28d
Vera plunges as Otsuka updates on rival therapy
Citing the Tokyo-based firm’s earnings results on Friday, Evercore ISI analyst Liisa Bayko argued that Otsuka’s (OTCPK:OTSKY) sibeprenlimab, which rivals Vera’s (NASDAQ:VERA) atacicept in ...